Avapro and Glaucoma - a phase IV clinical study of FDA data

Summary:

Glaucoma is reported as a side effect among people who take Avapro (irbesartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Plavix, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Glaucoma when taking Avapro. It is created by eHealthMe based on reports of 18,804 people who have side effects when taking Avapro from the FDA, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,233 drugs and 1,656 conditions by eHealthMe. Check the latest studies of Glaucoma.

On Aug, 11, 2026

18,804 people reported to have side effects when taking Avapro.
Among them, 51 people (0.27%) have Glaucoma.

Among these 51 people:

How long have people been on Avapro when they have Glaucoma? *

What is the gender of people who have Glaucoma when taking Avapro? *

female: 86.27 %
male: 13.73 %

What is the age of people who have Glaucoma when taking Avapro? *

What are other drugs people take besides Avapro? *

What are other side effects people have besides Glaucoma? *

Dizziness: 18 people, 35.29%
Cataract (clouding of the lens inside the eye): 15 people, 29.41%
Pain: 11 people, 21.57%
Weakness: 11 people, 21.57%
Vision Blurred: 11 people, 21.57%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 19.61%
Visual Impairment: 8 people, 15.69%
Loss Of Consciousness: 7 people, 13.73%
Drug Ineffective: 7 people, 13.73%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 13.73%

What are the existing conditions these people have? *

High Blood Cholesterol: 9 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 15.69%
Type 2 Diabetes: 7 people, 13.73%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 7 people, 13.73%
Neuropathy Peripheral (surface nerve damage): 6 people, 11.76%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 11.76%
Restless Leg Syndrome (a powerful urge to move your legs): 6 people, 11.76%
Diabetes: 4 people, 7.84%
Headache (pain in head): 4 people, 7.84%
Thyroid Diseases: 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and have Glaucoma?

- Check whether Glaucoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avapro:

Avapro (19,840 reports)

Glaucoma treatments and more:

Glaucoma (61,927 reports)

Browse all side effects of Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glaucoma:

Glaucoma (1,233 drugs)

Browse all the conditions that are associated with Glaucoma:

Glaucoma (1,656 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Avapro) and Avapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.